We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+8.75%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.69B
AUM Growth
-$542M
Cap. Flow
-$781M
Cap. Flow %
-21.18%
Top 10 Hldgs %
56.86%
Holding
480
New
156
Increased
61
Reduced
86
Closed
113

Top Buys

Rank Stock Value
1
SKX
Skechers
SKX
+$207M
2
BPMC
Blueprint Medicines
BPMC
+$176M
3
WBA
Walgreens Boots Alliance
WBA
+$167M
4
DNB
Dun & Bradstreet
DNB
+$122M
5
INFA
Informatica
INFA
+$93.8M

Top Sells

Rank Stock Value
1
DFS
Discover Financial Services
DFS
+$408M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$408M
3
HES
Hess
HES
+$251M
4
BECN
Beacon Roofing Supply, Inc.
BECN
+$195M
5
BERY
Berry Global Group, Inc.
BERY
+$137M

Sector Composition

Rank Sector Weight
1 Healthcare 19.77%
2 Technology 14.28%
3 Consumer Staples 10.98%
4 Energy 9.87%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSAIW icon
351
MultiSensor AI Holdings Warrant
MSAIW
$923K
$4.09K ﹤0.01%
142,585
– –
NVDA icon
352
PUT
NVIDIA
NVDA
$5.56T
$3.5K ﹤0.01%
+20,000
New +$2.52M
NVO
353
CALL
Novo Nordisk
NVO
$206B
$3.4K ﹤0.01%
+20,000
New +$1.36M
RDZNW icon
354
Roadzen Inc Warrants
RDZNW
$6.07M
$3.36K ﹤0.01%
65,696
– –
OPTXW icon
355
Syntec Optics Holdings Warrant
OPTXW
$17.6M
$2.78K ﹤0.01%
32,034
– –
BSLKW
356
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$2.4K ﹤0.01%
110,914
– –
GILD icon
357
PUT
Gilead Sciences
GILD
$187B
$360 ﹤0.01%
18,000
-8,000
-31% -$851K
KDKRW
358
Kodiak AI Warrants
KDKRW
– –
-82,711
Closed -$23.6K
AAPL icon
359
Apple
AAPL
$4.67T
– –
-10,000
Closed -$2.02M
ACRV icon
360
Acrivon Therapeutics
ACRV
$91.3M
– –
-15,576
Closed -$31.6K
AENTW icon
361
Alliance Entertainment Holding Corp Warrants
AENTW
– –
-60,000
Closed -$13.4K
AER icon
362
CALL
AerCap
AER
$22.9B
– –
-112,500
Closed -$59.1K
AES icon
363
CALL
AES
AES
$10.6B
– –
-150,000
Closed -$52.5K
AKAM icon
364
CALL
Akamai
AKAM
$15.1B
– –
-37,500
Closed -$14.1K
AKRO
365
DELISTED
Akero Therapeutics
AKRO
– –
-18,800
Closed -$761K
AMX icon
366
America Movil
AMX
$68.9B
– –
-253,922
Closed -$3.61M
APH icon
367
Amphenol
APH
$204B
– –
-239,880
Closed -$7.87M
APTV icon
368
Aptiv
APTV
$9.96B
– –
-46,000
Closed -$2.74M
ARQT icon
369
Arcutis Biotherapeutics
ARQT
$3B
– –
-13,201
Closed -$206K
OPTU
370
Optimum Communications Inc
OPTU
$401M
– –
-1,200,000
Closed -$3.19M
AURA icon
371
Aura Biosciences
AURA
$784M
– –
-151,108
Closed -$885K
BABA icon
372
Alibaba
BABA
$281B
– –
-35,447
Closed -$4.69M
BMRN icon
373
BioMarin Pharmaceuticals
BMRN
$12.9B
– –
-5,258
Closed -$372K
BPMC
374
PUT
DELISTED
Blueprint Medicines
BPMC
– –
-10,000
Closed -$30.8K
BZ icon
375
Kanzhun
BZ
$7.56B
– –
-143,000
Closed -$2.74M
13 14
15
16 17

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q2 2025 Portfolio in Review

As of Q2 2025, UBS O'Connor held 480 positions worth $3.69B, down 13% from $4.23B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

UBS O'Connor withdrew a net $781M in Q2 2025, closing 113 positions and reducing 86 holdings. Its most notable exit was Discover Financial Services, an estimated $408M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, UBS O'Connor opened a new position in Skechers worth $227M.

  • UBS O'Connor's largest Q2 2025 buy was Skechers: 3,598,177 shares worth $227M.
  • UBS O'Connor added most to Blueprint Medicines in Q2 2025, an estimated $176M increase.
  • UBS O'Connor's biggest Q2 2025 reduction was Hess, cutting an estimated $251M.
  • UBS O'Connor fully exited Discover Financial Services in Q2 2025, selling an estimated $408M.
  • UBS O'Connor's ten largest holdings make up 57% of its $3.69B portfolio in Q2 2025.
  • UBS O'Connor opened 156 new positions and closed 113 in Q2 2025.
  • UBS O'Connor's portfolio value fell 13% quarter-over-quarter to $3.69B.

Based on UBS O'Connor's 13F filing for Q2 2025, filed 14 Aug 2025.